All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Advertisement

Enter at least 3 characters to search the full directory.

Results

Showing 1–14 of 14 drugs · filtered

LIBTAYO (cemiplimab-rwlc)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · BASAL CELL CARCINOMA OF SKIN ·+3
Regeneron Pharmaceuticals, Inc.
Sponsored

OPDIVO (nivolumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · MALIGNANT ESOPHAGEAL NEOPLASM ·+17
BMS PRIMARYCARE

KEYTRUDA (pembrolizumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · MALIGNANT MELANOMA ·+36
Merck Sharp & Dohme

TECENTRIQ (atezolizumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · SMALL CELL LUNG CARCINOMA ·+8
GENENTECH

BAVENCIO (avelumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · RENAL CELL CARCINOMA ·+2
EMD SERONO, INC

IMFINZI (durvalumab)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · BILIARY TRACT MALIGNANCY ·+10
AstraZeneca Pharmaceuticals

ZYNYZ (retifanlimab-dlwr)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · MERKEL CELL CARCINOMA ·+1
Incyte Corporation

TEVIMBRA (tislelizumab-jsgr)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · PD-L1 POSITIVE SQUAMOUS CELL CARCINOMA OF ESOPHAGUS ·+5
BEONE MEDICINES

UNLOXCYT (cosibelimab-ipdl)

ANTINEOPLASTIC - ANTI-PROGRAMMED DEATH-(PD-1/L1) MC ANTIBODY · SQUAMOUS CELL CARCINOMA OF SKIN
SUN PHARMACEUTI